Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,116 | 566 | 90.2% |
| Consulting Fee | $644.00 | 1 | 5.2% |
| Travel and Lodging | $295.66 | 2 | 2.4% |
| Education | $273.38 | 5 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,572 | 139 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,469 | 30 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,328 | 70 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,154 | 52 | $0 (2024) |
| LEO Pharma Inc. | $841.03 | 40 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $833.98 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $620.66 | 25 | $0 (2024) |
| UCB, Inc. | $561.02 | 26 | $0 (2024) |
| PFIZER INC. | $473.45 | 26 | $0 (2024) |
| Lilly USA, LLC | $359.45 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,466 | 163 | ABBVIE INC. ($876.01) |
| 2023 | $4,264 | 155 | E.R. Squibb & Sons, L.L.C. ($1,204) |
| 2022 | $2,724 | 158 | ABBVIE INC. ($547.00) |
| 2021 | $1,875 | 98 | SUN PHARMACEUTICAL INDUSTRIES INC. ($351.28) |
All Payment Transactions
574 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Immunology | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.43 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $87.36 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.88 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.42 | General |
| Category: Immunology | ||||||
| 11/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Immunology | ||||||
| 11/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.24 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $53.77 | General |
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,944 | 3,189 | $516,516 | $135,321 |
| 2022 | 19 | 2,020 | 3,456 | $554,783 | $144,633 |
| 2021 | 19 | 2,032 | 3,851 | $615,997 | $161,021 |
| 2020 | 16 | 2,222 | 3,979 | $636,329 | $162,020 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 493 | 626 | $131,460 | $42,298 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 442 | 577 | $86,550 | $27,804 | 32.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 40 | 49 | $29,400 | $14,764 | 50.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 199 | 232 | $58,000 | $14,699 | 25.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 218 | 317 | $57,060 | $10,845 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 145 | 158 | $37,130 | $8,479 | 22.8% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 40 | 46 | $20,746 | $6,295 | 30.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 164 | 928 | $66,816 | $3,697 | 5.5% |
| 96405 | Administration of chemotherapy into growth, 1-7 | Office | 2023 | 26 | 33 | $10,230 | $1,578 | 15.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,480 | $1,208 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,740 | $894.63 | 23.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $2,430 | $844.68 | 34.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 20 | 21 | $2,625 | $642.83 | 24.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,700 | $462.10 | 17.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 39 | $975.00 | $327.60 | 33.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 29 | $1,160 | $220.69 | 19.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 13 | 25 | $750.00 | $200.25 | 26.7% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2023 | 26 | 33 | $264.00 | $58.82 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 480 | 633 | $132,930 | $45,000 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 426 | 579 | $86,850 | $28,706 | 33.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 211 | 241 | $60,250 | $15,295 | 25.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 33 | 45 | $27,000 | $13,642 | 50.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 234 | 344 | $61,920 | $11,401 | 18.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 160 | 183 | $43,005 | $9,826 | 22.8% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 31 | 36 | $16,236 | $5,164 | 31.8% |
About Edith Saffo, NP
Edith Saffo, NP is a Nurse Practitioner healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235296013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edith Saffo, NP has received a total of $12,329 in payments from pharmaceutical and medical device companies, with $3,466 received in 2024. These payments were reported across 574 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($11,116).
As a Medicare-enrolled provider, Saffo has provided services to 8,218 Medicare beneficiaries, totaling 14,475 services with total Medicare billing of $602,995. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Wilmington, NC
- Active Since 01/02/2007
- Last Updated 01/17/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1235296013
Products in Payments
- Sotyktu (Drug) $1,469
- RINVOQ (Biological) $1,165
- DUPIXENT (Biological) $1,148
- SKYRIZI (Biological) $888.33
- ILUMYA (Biological) $728.54
- ADBRY (Biological) $675.91
- COSENTYX (Drug) $642.34
- TREMFYA (Drug) $614.95
- COSENTYX (Biological) $511.93
- TALTZ (Drug) $339.64
- HUMIRA (Biological) $331.61
- EUCRISA (Drug) $302.74
- Bimzelx (Biological) $263.20
- Ilumya (Biological) $256.76
- OPZELURA (Drug) $224.61
- VTAMA (Drug) $212.52
- Klisyri (Drug) $199.17
- Cimzia (Drug) $170.90
- CIBINQO (Drug) $170.71
- DUOBRII (Drug) $116.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wilmington
Bridgette Williams, Fnp, FNP
Nurse Practitioner — Payments: $32,695
Mrs. Colleen Ditro, Apn, APN
Nurse Practitioner — Payments: $16,224
Lauren Gardner, Np, NP
Nurse Practitioner — Payments: $13,768
Rebecca Maphis
Nurse Practitioner — Payments: $12,076
Jennifer Hubbard, Aprn, APRN
Nurse Practitioner — Payments: $10,691
Anna Paylor
Nurse Practitioner — Payments: $7,248